Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Spotify Technology — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while Spotify Technology trades at $529.14 (market cap $108.22B). The key difference: Spotify Technology is far larger — about 17.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Spotify Technology for 111 Days on average.
| IOVA | SPOT | |
|---|---|---|
Market Cap | $6.04B | $108.22B |
Volume | 14,805,993 | 1,655,796 |
Sector | Health | Media |
52-Week High | $14.82 | $692.04 |
52-Week Low | $1.81 | $412.75 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $5.97B | $98.23B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Spotify (SPOT) trades at $529.14, up 3.16% with strong technical momentum above key support levels. The company demonstrates robust fundamental performance with revenue growth from $15.7B to $17.2B in 2025 and net income surging to $2.2B. Recent earnings show mixed results with two beats and one miss, while analyst consensus remains strongly bullish with a $606.50 price target. Technical indicators show bullish moving averages but neutral oscillators, with RSI suggesting potential overbought conditions near-term.
Spotify presents a compelling growth story with expanding profit margins and strong cash flow generation. Key opportunities include continued subscriber growth and new monetization tools, while risks involve competitive pressures and execution challenges. The stock trades near the lower end of analyst targets, offering potential upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
